XML 52 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
LOANS RECEIVABLE AND INVESTMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Loans Receivable And Investments [Abstract]  
Loans Receivable And Investments The following is a summary of our loans receivable and investments, net, including amortized cost, fair value and unrealized gains or losses on available for sale investments (dollars in thousands):
Amortized CostAllowanceCarrying AmountFair Value
As of December 31, 2023:
Secured/mortgage loans and other, net (1)
$27,986 $— $27,986 $27,947 
Non-mortgage loans receivable, net (2)
30,128 (3,976)26,152 25,200 
Total loans receivable and investments, net$58,114 $(3,976)$54,138 $53,147 
As of December 31, 2022:
Secured/mortgage loans and other, net (3)
$513,669 $(20,000)$493,669 $493,627 
Government-sponsored pooled loan investments, net (4)
43,406 — 43,406 43,406 
Total investments reported as secured loans receivable and investments, net
557,075 (20,000)537,075 537,033 
Non-mortgage loans receivable, net (2)
28,959 (4,621)24,338 23,416 
Total loans receivable and investments, net$586,034 $(24,621)$561,413 $560,449 
______________________________
(1)Investments have contractual maturities in 2024 and 2027.
(2)Included in other assets on our Consolidated Balance Sheets.
(3)Includes the Company’s cash-pay non-recourse mezzanine loan to Santerre Health Investors (the “Santerre Mezzanine Loan”), which was no longer outstanding as of December 31, 2023. Other included investments have contractual maturities in 2024 and 2027.
(4)Repaid at par in February 2023.